China Starts Building First Giant Supercomputer Network in Space
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
China has begun launching satellites for a giant computer network in space, according to the China Aerospace Science and Technology Corporation.
Newsweek contacted the company and the United States Space Force for comment.
Why It Matters
Space is an increasing frontier for competition between China and the United States. Putting a computer network in space marks a step change from using satellites for sensing and communications, but leaving them dependent on their connections to Earth for data processing.
The satellite constellation planned by China would allow the network to operate free of such constraints. It would avoid the need for the costly cooling systems that Earth-based computing requires and remove it from the risks of being tied to the ground — also providing potential military advantages in the event of conflict.
The new network's artificial intelligence capabilities highlight the intensification of the AI race between China and the United States.
What To Know
The state-owned China Aerospace Science and Technology Corporation said that 12 satellites were launched from the Jiuquan Satellite Launch Center in northern China aboard a Long March 2D rocket on May 14.
"It successfully sent the space computing satellite constellation into the predetermined orbit. The launch mission was a complete success," it said. "The space computing satellite constellation is the first constellation of the 'Star Computing' program."
The satellites of the Star Computing program are developed by the Guoxing Aerospace Corporation.
The plan is to have 2,800 satellites that will be connected to each other by laser in a single computing network, according to the Chinese-language ST daily, the official newspaper of the Ministry of Science and Technology.
Image representing data processing in space
Image representing data processing in space
AI generated
The number of satellites is still small compared to the Starlink communications network of Elon Musk's SpaceX, which is the world's largest satellite constellation and had more than 6,750 satellites in orbit by the end of February, according to the company. Launches continue and it may eventually expand to over 30,000 satellites.
In a sign of the U.S.-China space rivalry, an American military satellite was tracked "buzzing" its Chinese counterparts recently. Chinese space projects in Latin America have become a concern for the United States, a top U.S. general warned.
What People Are Saying
The Chinese Ministry of Science and Technology's ST Daily: "The construction of the first constellation will build a future computing network... meet the growing demand for real-time computing in space, and help the country take the lead in building global space computing infrastructure, take the commanding heights of the path of the future industry and break through the boundaries of the field of artificial intelligence from the ground to space."
Jonathan McDowell of Harvard University, quoted by the South China Morning Post: "Orbital data centres can use solar power and radiate their heat to space, reducing the energy needs and carbon footprint... Today's Chinese launch is the first substantial flight test of the networking part of this concept."
What Happens Next
China is expected to intensify research as it seeks to surpass the United States in space technologies, high speed computing and artificial intelligence.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Big Tech's AI Endgame Is Coming Into Focus
If Google has its way, there will be no search bars, no search terms, no searching (at least not by humans). The very tool that has defined the company—and perhaps the entire internet—for nearly three decades could soon be overtaken by a chatbot. Last month, at its annual software conference, Google launched 'AI Mode,' the most drastic overhaul to its search engine in the company's history. The feature is different from the AI summaries that already show up in Google's search results, which appear above the usual list of links to outside websites. Instead, AI Mode functionally replaces Google Search with something akin to ChatGPT. You ask a question and the AI spits out an answer. Instead of sifting through a list of blue links, you can just ask a follow-up. Google has begun rolling out AI Mode to users in the United States as a tab below the search bar (before 'Images,' 'Shopping,' and the like). The company said it will soon introduce a number of more advanced, experimental capabilities to AI Mode, at which point the feature could be able to write a research report in minutes, 'see' through your smartphone's camera to assist with physical tasks such as a DIY crafts project, help book restaurant reservations, make payments. Whether AI Mode can become as advanced and as seamless as Google promises remains far from certain, but the firm appears to be aiming for something like an everything app: a single tool that will be able to do just about everything a person could possibly want to do online. Seemingly every major tech company is after the same goal. OpenAI markets ChatGPT, for instance, as able to write code and summarize documents, help shop, produce graphics, and naturally, search the web. Elon Musk is notoriously obsessed with the idea of turning X into an everything app. Meta says you can use its AI 'for everything you need'; Amazon calls its new, generative AI–powered Alexa+ 'an assistant available to help any time you want'; Microsoft bills its AI Copilot as a companion 'for all you do'; and Apple has marketed Apple Intelligence and a revamped Siri as tools that will revolutionize how people use their iPhones (which encompass, for many users, everything). Even Airbnb, once focused simply on vacation rentals, is redesigning itself as a place where 'you can sell and do almost anything,' as its CEO, Brian Chesky, recently said. In a sense, everything apps are the logical conclusion of Silicon Valley's race to build artificial 'general' intelligence, or AGI. A bot smart enough to do anything obviously would be used to power a product that can, in effect, do anything. But such apps would also represent the culmination of the tech industry's aim to entrench its products in people's daily lives. Already, Google has features for shopping, navigation, data storage, work software, payment, travel—plus an array of smartphones, tablets, smart-home gadgets, and more. Apple has a similarly all-encompassing suite of offerings, and Meta's three major apps (Facebook, Instagram, and WhatsApp) each have billions of users. Perhaps the only thing more powerful than these sprawling tech ecosystems is boiling them all down to a single product. That these tech companies can even realistically have such colossal ambitions to build everything apps is a result of their existing dominance. The industry has spent years collecting information about our relationships, work, hobbies, and interests—all of which is becoming grist for powerful AI tools. A key feature of these everything apps is that they promise to be individually tailored, drawing on extensive personal data to provide, in theory, a more seamless experience. Your past search history, and eventually your emails, can inform AI Mode's responses: When I typed line up into AI Mode, I got the 'line up' for the day's New York Mets game (the Mets are my favorite baseball team). When I typed the same phrase into traditional Google Search, I got a definition. In other words, the rise of AI-powered everything apps is a version of the bargain that tech companies have proposed in the past with social media and other tools: our services for your data. Meta's AI assistant can draw on information from users' Facebook and Instagram accounts. Apple describes its AI as a 'personal intelligence' able to glean from texts, emails, and notes on your device. And ChatGPT has a new 'memory' feature that allows the chatbot to reference all previous conversations. If the technology goes as planned, it leads to a future in which Google, or any other Big Tech company, knows you are moving from Texas to Chicago and, of its own accord, offers to order the winter jacket you don't own to be delivered to your new apartment, already selected from your favorite brand, in your favorite color. Or it could, after reading emails musing about an Italian vacation, suggest an in-budget itinerary for Venice that best fits your preferences. There are, of course, plenty of reasons to think that AI models will not be capable and reliable enough to power a true everything app. The Mets lineup that Google automatically generated for me wasn't entirely accurate. Chatbots still invent information and mess up basic math; concerns over AI's environmental harms and alleged infringement of intellectual-property rights could substantially slow the technology's development. Only a year ago, Google released AI Overviews, a search feature that told users to eat rocks and use glue to stick cheese to pizza. On the same day that Google released AI Mode, it also introduced an experimental AI shopping tool that can be easily used to make erotic images of teenagers, as I reported with my colleague Lila Shroff. (When we shared our reporting with the company, Google emphasized the protections it has in place and told us it would 'continue to improve the experience.') Maybe AI Mode will order something two sizes too large and ship to the wrong address, or maybe it'll serve you recommendations for Venice Beach. [Read: Google's new AI puts breasts on minors—and J.D. Vance] Despite these embarrassments, Google and its major AI competitors show no signs of slowing down. The promised convenience of everything apps is, after all, alluring: The more products of any one company you use, and the better integrated those products are, the more personalized and universal its everything app can be. Google even has a second contender in the race—its Gemini model, which, at the same conference, the company said will become a 'universal AI assistant.' Whether through Search or Gemini the company seems eager to integrate as many of its products and as much of its user data as possible. On the surface, AI and the everything app seem set to dramatically change how people interact with technology—consolidating and streamlining search, social media, officeware, and more into a chatbot. But a bunch of everything apps vying for customers feels less like a race for innovation and more like empires warring over territory. Tech companies are running the same data-hungry playbook with their everything apps as they did in the markets that made them so dominant in the first place. Even OpenAI, which has evolved from a little-known nonprofit to a Silicon Valley behemoth, appears so eager to accumulate user data that it reportedly plans to launch a social-media network. The technology of the future looks awfully reliant on that of the past. Article originally published at The Atlantic
Yahoo
an hour ago
- Yahoo
Army surveillance balloons spotted over Tucson raise privacy concerns from advocates
An Aerostar high-altitude balloon as seen from the ground in Tucson. Photo by Dugan Meyer The U.S. Army and a private company are flying high-altitude surveillance balloons over the Tucson area, raising concerns among privacy advocates. Multiple high-altitude balloons have been spotted over the Tucson and Sierra Vista area for more than a week, with one balloon in particular staying over the area longer than any of the others. That balloon, with the registration number N257TH, has made headlines in the past. The balloon is owned by South Dakota aerospace company Aerostar, and in 2023 was mistaken for a Chinese spy balloon. The balloon is actually part of Aerostar's 'Thunderhead' balloon system, which has been doing multiple tests with the military and other contractors across the nation and around the globe. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX 'It is a technology that should not and constitutionally cannot be applied to the American people,' Jay Stanley, a senior policy analyst at the American Civil Liberties Union, told the Arizona Mirror. 'Even testing for eventual overseas use in legitimate combat theaters raises a lot of questions about what kind of data is being collected.' Aerostar would not answer specific questions about what type of testing was being done. The company referred additional questions to the U.S. Department of Defense and the Army, neither of which responded to multiple requests for comment. Aerostar confirmed that the flights were not connected to U.S. Customs and Border Patrol or Department of Homeland Security programs, 'however high-altitude balloons would be ideal for that type of mission,' Aerostar Culture and Communications Director Anastasia Quanbeck said in an email to the Mirror. 'By leveraging directional wind patterns at high altitudes, Aerostar's Thunderhead Balloon Systems offer groundbreaking capabilities for navigation and persistence over areas of interest,' she said. 'Aerostar Thunderhead Balloon Systems are capable of supporting intelligence, surveillance, and reconnaissance missions, as well as extending communications across wide distances, environmental monitoring, earth observation, and scientific research.' Quanbeck said she was not able to discuss the work the company does with the DOD or the Army. The 'Thunderhead' balloons are similar to 'spy balloons' that have made international headlines in recent years. They fly between 60,000 to 100,000 feet, twice the height of a commercial airliner, and can carry much larger payloads than a conventional drone or other small high altitude spy-planes. After Chinese spy-balloons made incursions into United States airspace in 2023, it was reported that the Army would begin pursuing a similar program to launch in 2025. Aerostar had previously been used in testing exercises. In the past, Aerostar has used blimps as surveillance systems. They were originally used for surveillance in combat zones overseas, then in 2012 were used along the border and still are often spotted at the border today. However, the systems that have been seen floating over southern Arizona in recent weeks have key differences from the blimps: they sit higher in the sky, are much larger, can stay afloat for much longer and can carry larger payloads. As reported by The War Zone, the Army has been researching using high-altitude balloons to deploy drone swarms into enemy territory far above the reach of enemy defenses. But the balloons over southern Arizona raise questions about privacy. In 2021, the 4th U.S. Circuit Court of Appeals ruled that the Baltimore Police Department's use of an aerial surveillance program that recorded virtually all of the city for 12 hours a day for six months was unconstitutional. Stanley thinks that case is pertinent when talking about what may be going on in Arizona. 'I think, if anything, it becomes more sensitive when the military is doing it,' Stanley said. Wide-area persistent surveillance or wide-area airborne surveillance is a technique that got its start in early days of the Iraq war but later would find itself in the hands of police. The technology has evolved from being very heavy but is now light enough to fit onto blimps and balloons. Aerostar and the military have not elaborated on what systems are aboard the balloons over the Tucson area, but Stanley said that systems like the ones Aerostar is developing could be used to deploy persistent surveillance systems, ultimately surveilling entire communities for days on end. The Thunderhead system boasts the ability to stay afloat for up to 30 days, and Aerostar has tested it along with its Zephyr platform, a new type of unmanned aircraft that also flies at high altitudes and has been tested in Arizona. That aircraft can stay in the air for up to two months. The balloon also could be carrying a variety of equipment, such as radar, lidar, GPS or cameras, Stanley said. While much of this equipment could be installed on a traditional aircraft, the balloon can stay afloat over an area at a higher altitude for longer durations, allowing for more persistent surveillance of an area, something that Stanley said can be a problem for everyday Americans. 'Following someone around for long periods of time reveals things about their life,' Stanley said. 'How often they go to the bar, associations, who they are hanging out with — and that is too much power for the government or anyone else to have over individuals.' SUPPORT: YOU MAKE OUR WORK POSSIBLE
Boston Globe
an hour ago
- Boston Globe
From no hope to a potential cure for a deadly blood cancer
A third responded so well that they got what seems to be an astonishing reprieve. The immunotherapy developed by Legend Biotech, a company founded in China, seems to have made their cancer disappear. And after five years, it still has not returned in those patients -- a result never before seen in this disease. Advertisement These results, in patients whose situation had seemed hopeless, has led some battle-worn American oncologists to dare to say the words 'potential cure.' Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up 'In my 30 years in oncology, we haven't talked about curing myeloma,' said Dr. Norman Sharpless, a former director of the National Cancer Institute who is now a professor of cancer policy and innovation at the University of North Carolina School of Medicine. 'This is the first time we are really talking seriously about cure in one of the worst malignancies imaginable.' The new study, reported Tuesday at the annual conference of the American Society of Clinical Oncology and published in The Journal of Clinical Oncology, was funded by Johnson & Johnson, which has an exclusive licensing agreement with Legend Biotech. The 36,000 Americans who develop multiple myeloma each year face an illness that eats away at bones, so it looks as if holes have been punched out in them, said Dr. Carl June, of the University of Pennsylvania. Bones collapse. June has seen patients who lost 6 inches in height. Advertisement 'It's a horrible, horrible death,' June said. 'Right now advanced myeloma is a death sentence.' (June has immunotherapy patents that are owned by his university.) There have been treatment advances that increased median survival from two years to 10 over the past two decades. But no cures. Dr. Peter Voorhees of the Atrium Health Levine Cancer Institute in North Carolina and the Wake Forest University School of Medicine, who is lead researcher for the newly published study, said patients usually go through treatment after treatment until, ultimately, the cancer prevails, developing resistance to every class of drug. They end up with nothing left to try. The Legend immunotherapy is a type known as CAR-T. It is delivered as an infusion of the patient's own white blood cells that have been removed and engineered to attack the cancer. The treatment has revolutionized prospects for patients with other types of blood cancer, like leukemia. Making CAR-T cells, though, is an art, with so many possible variables that it can be hard to hit on one that works. And it can have severe side effects including a high fever, trouble breathing and infections. Patients can be hospitalized for weeks after receiving it. But Legend managed to develop one that works in multiple myeloma, defying skeptics. The Chinese company gained attention for its CAR-T eight years ago when it made extravagant claims, which were met by snickers from American researchers. Advertisement Johnson & Johnson, though, was looking for a CAR-T to call its own. So, said Mark Wildgust, an executive in the oncology section of the American drug giant, the company sent scientists and physicians to China to see if the claims were true. 'We went site by site to look at the results,' he said. The company was convinced. It initiated a collaboration with Legend and began testing the treatment in patients whose myeloma had overcome at least one standard treatment. Compared with patients who had standard treatment, those who had the immunotherapy lived longer without their disease progressing. The immunotherapy received regulatory approval in that limited setting and is sold under the brand name Carvykti. The study did not determine whether this difficult treatment saved lives. The new study took on a different challenge -- helping patients at the end of the line after years of treatments. Their immune systems were worn down. They were, as oncologists said, 'heavily pretreated.' So even though CAR-T is designed to spur their immune systems to fight their cancer, it was not clear their immune systems were up to it. Oncologists say that even though most patients did not clear their cancer, having a third who did was remarkable. To see what the expected life span would be for these patients without the immunotherapy, Johnson & Johnson looked at data from patients in a registry who were like the ones in its study -- they had failed every treatment. They lived about a year. For Anne Stovell of New York, one of the study patients whose cancer disappeared, the result is almost too good to be true. She says she went through nine drugs to control her cancer after it was diagnosed in 2010, some of which had horrendous side effects. Each eventually failed. Advertisement Taking the Legend CAR-T was difficult -- she said she had spent nearly three weeks in the hospital. But since that treatment six years ago, she has no sign of cancer. She said it was still difficult for her to believe her myeloma is gone. A new ache -- or an old one -- can bring on the fear. 'There's that little seed of doubt,' she said. But in test after test, the cancer has not reappeared. 'It's a relief for me every year to get a bone marrow biopsy,' she said. Myeloma experts applauded the results. Like treatments for many other cancers, treatments for multiple myeloma come with a high price. The drugs are 'hideously expensive,' June said, costing more than $100,000 a year. The total cost over the years can be millions of dollars, June said, usually paid by insurers, 'and it doesn't even cure you.' CAR-T is expensive too. Carvykti's list price is $555,310. But it is a one-time treatment. And, more important, the hope is that perhaps by giving it earlier in the course of the disease, it could cure patients early on. Johnson & Johnson is now testing that idea. Dr. Kenneth Anderson, a myeloma expert at Dana-Farber Cancer Institute who was not involved with the study, said that if the treatment is used as a first-line treatment, 'cure is now our realistic expectation.' That, at least, is the hope, Sharpless said. And for those like the patients in the new study who are living at least five years -- so far -- without disease, the outcome 'really is eye-popping,' Sharpless said. Advertisement 'That's getting to a point where you wonder if it will ever come back,' he added. This article originally appeared in
